{"id":6017,"date":"2014-06-20T11:13:00","date_gmt":"2014-06-20T11:13:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/a-type-of-rx-drug-tweet-fda-did-no\/"},"modified":"2019-02-21T01:16:33","modified_gmt":"2019-02-21T01:16:33","slug":"a-type-of-rx-drug-tweet-fda-did-no","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/","title":{"rendered":"A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance"},"content":{"rendered":"

I couldn’t sleep last night. For some reason I became obsessed with trying to figure out a way that pharma companies can  create Rx branded tweets that satisfy  FDA’s recent “Industry Guidance for Internet\/Social Media Platforms with Character Space Limitations \u2014 Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices.”<\/p>\n

Is it possible?<\/p>\n

In a comment to the FDA on Regulation.gov<\/a>, I described a Tweet that may pass muster with the FDA.<\/p>\n

Here’s my comment:<\/p>\n

“The draft guidance does not mention Tweets accompanied by images, which is perhaps a way to present ISI along with benefit information in the tweet itself,” I said. “I have created a mock-up using Lipitor as an example.”<\/p>\n

 Here’s a screen shot of how this tweet would look on Twitter:<\/p>\n

<\/a><\/p>\n\n\n\n\n
<\/a><\/td>\n<\/tr>\n
My mockup of an ad that may pass FDA muster re Branded Rx Tweets<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

In this mockup, the character portion of the tweet contains the required trade name and established scientific name plus refers to the indication (“high cholesterol”) and includes a link to a page devoted to the risks.<\/p>\n

The shortened version of the URL makes it plain that the link is to a page devoted to risks — a requirement mentioned in the guidance. That page also links to the coupon information, which is OK to do according to the FDA guidance document.<\/p>\n

In addition, the tweet includes the total ISI (important safety information) as a JPG image, which is clearly readable on the Twitter page as shown in the screen shot above.<\/p>\n

A caveat<\/b>: An image takes 26 characters away from the tweet, so there is even less space to use for promotion. But as my example shows, it’s possible.<\/p>\n

My question: Do tweets such as this satisfy the requirements of the guidance document?<\/p>\n

What’s your opinion?<\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

I couldn’t sleep last night. For some reason I became obsessed with trying to figure out a way that pharma companies can  create Rx branded tweets that satisfy  FDA’s recent “Industry Guidance for Internet\/Social Media Platforms with Character Space Limitations \u2014 Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices.” Is it possible? […]<\/p>\n","protected":false},"author":2,"featured_media":11593,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[304,113,44,145,128,450,280],"topic":[],"acf":[],"yoast_head":"\nA Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"I couldn’t sleep last night. For some reason I became obsessed with trying to figure out a way that pharma companies can  create Rx branded tweets that satisfy  FDA’s recent “Industry Guidance for Internet\/Social Media Platforms with Character Space Limitations \u2014 Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices.” Is it possible? […]\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-20T11:13:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-21T01:16:33+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2014\/06\/Lipitor-Tweet-Mockup.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"536\" \/>\n\t<meta property=\"og:image:height\" content=\"395\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/\",\"name\":\"A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2014-06-20T11:13:00+00:00\",\"dateModified\":\"2019-02-21T01:16:33+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/","og_locale":"en_US","og_type":"article","og_title":"A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance - Pharma Marketing Network","og_description":"I couldn’t sleep last night. For some reason I became obsessed with trying to figure out a way that pharma companies can  create Rx branded tweets that satisfy  FDA’s recent “Industry Guidance for Internet\/Social Media Platforms with Character Space Limitations \u2014 Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices.” Is it possible? […]","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/","og_site_name":"Pharma Marketing Network","article_published_time":"2014-06-20T11:13:00+00:00","article_modified_time":"2019-02-21T01:16:33+00:00","og_image":[{"width":536,"height":395,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2014\/06\/Lipitor-Tweet-Mockup.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/","name":"A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2014-06-20T11:13:00+00:00","dateModified":"2019-02-21T01:16:33+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/blog\/a-type-of-rx-drug-tweet-fda-did-no\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"A Type of Rx Drug Tweet FDA Did Not Consider in its Recent Guidance"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6017"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=6017"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6017\/revisions"}],"predecessor-version":[{"id":11594,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/6017\/revisions\/11594"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/11593"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=6017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=6017"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=6017"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=6017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}